BioPharma Services >> QC Services >> Early Development

Early Development

Sidebar Image

In Scandinavia we offer a single contact person to establish a tailor-made project organisation around your drug development portfolio

Premium CRO with outstanding expertise

We provide an industry-leading network of expertise in pre-clinical and clinical Research and Development (R&D). We are a decentralized, non-bureaucratic organisation offering the access to state of the art technology, large capacity, IT logistics and global presence. Our high growth rate is evidence of many client relationships and success.

Our complete project management includes an integrated service from strategic planning through seamless project conduct, to dossier preparation. In Scandinavia we offer a single contact person to establish a tailor-made project organisation around your drug development portfolio. This ensures the best possible start for your compounds and coordinated effort throughout the pre-clinical development phase.

Integrated approach of drug development

Preclinical drug development is a complex, regulatory and strategy-driven process.
Our activities encompass toxicology, pharmacology, metabolism, pharmaceutical analysis and biosafety testing. Our preclinical expertise in these areas is recognized in the pharmaceutical industry. Eurofins Pharma Services offers the advantage to host industry leading expertise in preclinical and clinical development within the same organization. This structure allows us to design the overall strategy for the benefit of your compound.

The coordination of the preclinical activity of your projects is targeted for a successful clinical development. We ensure timely, accurate and accessible data. Eurofins Pharma Services do not only deliver you the results but put these in the context due to our consultancy support. This integrated approach is making us different and it is the basis of the success of your projects and our business. With Eurofins Pharma Services you are in the position to speed up critical decisions that affect the progress of your compound.

Our network of expertise and full service is not only a matter of convenience but also an issue of confidence and security to succeed with your project. Our clients select Eurofins for this distinctive match of expertise, flexibility and full service.
This beneficial setting explains why we work for 8 out of the 10 biggest Pharma companies worlds-wide.

Early development Phase I and IIa studies

We have with Eurofins ׀ Optimed more than 80 beds in our clinical Phase I and IIa units based in Grenoble and Lyon (F). Patient safety, an efficient recruitment policy and the network of expertise within Eurofins are responsible for our outstanding reputation in the pharmaceutical, cosmetic and nutrition industry. The complete integration of Eurofins preclinical capabilities and clinical units into a full service of drug development is a real benefit for our clients. Eurofins ׀ Optimed provides an inclusive service during Phase I and IIa studies including e.g. bioanalysis, data management and preparation of the dossiers. For the next steps of the clinical development, Eurofins Pharma Services provide an outstanding support in the complex process for logistics, biomarker development, central lab and data management.